Phytotherapeutic potential of herbal supplements for COVID-19

HA Adekola, IA Adekunle, MO Alabi-Abass… - Arabian Journal of …, 2021 - revues.imist.ma
Abstract The current Coronavirus Disease-19 (COVID-19) pandemic caused by Severe
Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has reportedly posed a …

Proteomic understanding of SARS-CoV-2 infection and COVID-19: Biological, diagnostic, and therapeutic perspectives

F Al-Ejeh, M Merhi, M Al-Muftah, Q Fernandes… - Omics approaches and …, 2023 - Elsevier
The research community responded rapidly to the SARS-CoV-2 pandemic with a burst of
proteomic studies to understand this new virus. We focus in this chapter on proteomic …

[HTML][HTML] Clinical Outcomes after Immunotherapies in Cancer Setting during COVID-19 Era: A Systematic Review and Meta-Regression

M Kamal, M Baudo, J Joseph, Y Geng, A Qdaisat - Reports, 2022 - mdpi.com
Background: This study aims to describe COVID-19–related clinical outcomes after
immunotherapies (ICIs) for cancer patients. Methods: In this meta-analysis, we searched …

Hepatosplenic T-cell lymphoma with hemophagocytic lymphohistiocytosis, revealed by fever of unknown origin

K Meliani, N Alami Dribi, W Rhandour… - memo-Magazine of …, 2023 - Springer
The unusual peripheral lymphoma known as hepatosplenic T‑cell lymphoma (HSTCL) is a
rare hematologic cancer. In this report, we discuss a case of HSTCL with hemophagocytic …

Immunomodulators as New Emerging Virus Infections (Zika Virus Infection, MERS, and COVID-19)

S Yasri, V Wiwanitkit - … with Special Emphasis on Nutraceutical and …, 2023 - taylorfrancis.com
Infectious disease is a common problem in clinical medicine. The infection results from the
invasion of pathogen into the host and further cause inflammatory process that finalize into …

[HTML][HTML] Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households

A Anushiravani, B Saberzadeh-Ardestani… - Middle East Journal …, 2022 - ncbi.nlm.nih.gov
BACKGROUND: Immunosuppressive agents used in the treatment of inflammatory bowel
diseases (IBDs) could potentially increase the risk of coronavirus disease 2019 (COVID-19) …

and Min Wu

Z Wang, Q Pu, C Huang - … in Health and Disease, Volume I, 2021 - books.google.com
Acute and chronic lung inflammation is a risk factor for various diseases involving lungs and
extrapulmonary organs. Intercellular and interorgan networks, including crosstalk between …

Plasmasféresis, efectos adversos y sus horizontes en Covid-19.

L Mazo-Betancur… - Salutem …, 2022 - revistas.javerianacali.edu.co
La plasmaféresis es un procedimiento terapéutico que consiste en la extracción de sangre
con el fin de realizar posteriormente la separación de componentes celulares y plasma a …

Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders

ME Williams, BC Fielding - AIDS Research and Human …, 2021 - liebertpub.com
Severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2 is responsible for a new
coronavirus disease known as coronavirus disease-19 (COVID-19). SARS-CoV-2 reports …

The Effect of Covid-19 on Liver

HD Ali, AE Mahmood, BI Dheeb - Egyptian Academic Journal of …, 2022 - journals.ekb.eg
Wuhan City, China has reported the identification of the first occurrence of the respiratory
disease brought on by a new coronavirus since December 2019. Severe acute respiratory …